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Abstract
Background: Modified Blalock-Taussig shunt (MBTS) is considered as a simple procedure but has a considerable 
operative mortality rate. Patient’s characteristics who underwent MBTS in Indonesia is quite different than 
other country. There was no predictor of operative mortality has been identified in Indonesian. To compare 
mortality rate based on age criteria and to identify mortality and morbidity predictors after MBTS procedure.
Methods: A retrospectively cohort study was conducted on 400 patients who underwent MBTS at National 
cardiovascular center Harapan Kita (NCCHK) between January 2013 and december 2017. 
Results: There were 32,1% death at age ≤ 28 days, 19,9% at age 29-365 days, 3,6% at age 366-1825 days 
and 8% at age > 1825 days. Body weight < 3 kg, haematocrite level > 45% before procedure and activated 
partial thromboplastine time level (aPTT) < 60 seconds were operative mortality  predictors. Postoperative 
morbidity rate was 32,9%. Packed red cell  transfusion (PRC) more than 6 ml/kg, mechanical ventilator use 
before procedure, prostaglandin E1 use before procedure, aPTT level less than 60 seconds after procedure 
were identified as postoperative morbidity predictors.
Conclusion: Operative mortality rate significantly different among age criteria but it was not proven as an 
operative mortality predictors. Body weight < 3 kg increase mortality rate and haematocrite level higher than 
45% and aPTT level less than 60 seconds decrease mortality rate. Postoperative morbidity predictors were 
PRC transfusion more than 6ml/kg, mechanical ventilator use before procedure, prostaglandine E1 use and 
aPTT level less than 60 seconds.
(Indonesian J Cardiol. 2019;40:216-221)
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Introduction
The modified Blalock-Taussig shunt (MBTS) is commonly performed to deliver a reliable source of pulmonary blood flow in neonates born with complex congenital heart defects 
associated with pulmonary stenosis or atresia.(1) In spite 
of being a small operation, MBTS is associated with 
significant mortality risk of around 7–9%.(2) Bove et 
al., found out that the outcome of palliation with the 
MBTS is importantly affected by the occurrence of a 
doi: 10.30701/ijc.v40i1.763
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shunt-related complication.(3) Several shunt related 
complication has identified, such as shunt occlusion, 
shunt overcirculation that can increase mortality and 
manifest as congestive heart failure and necrotizing 
enterocolitis.(2)
 The resources to treat congenital heart disease are 
both inadequate and seriously maldistributed. The 
2007–2009 World Society for Paediatric Heart Surgery 
Manpower Survey noted that about 75% of the world’s 
population have no access to cardiac surgery, and that the 
distribution of cardiac surgeons was very unbalanced. 
This is in keeping with the variation in distribution of 
cardiovascular centres. This is often compounded by 
limited education of the population in the  developed 
nations.(4)
 In Indonesia, because of those limitation, the 
patient who underwent Blalock-Taussig shunt came 
to hospital in older age. Based on data from 2016-
2017 in National Cardiovascular Center Harapan Kita 
(NCCHK), overall mortality was 13,5% with 1,5%, 
41% and 57,5% population proportion underwent 
BTS were neonates, infants and older children or aldult 
respectively. It is noted that, there were 11% proportion 
older than 10 years old. Because of the different 
population characteristics and higher mortality than 
other study, it is important to identify the predictors of 
mortality in Indonesia.
Methods 
Data were retrospectively collected from clinical records 
of all patients undergoing an MBTS at NCCHK, 
from January 2013 to December 2017. Approval of 
the ethical committee of the NCCHK was obtained 
for this study, and informed consent was waived for its 
retrospective design. Inclusion criteria was all MBTS 
procedure and any concomitant procedure other than 
surgical closure of patent ductus arteriosus (PDA) and 
major aortopulmonary collateral arteries (MAPCAs), 
pulmonary artery repair and atrial septectomy were 
grounds for exclusion. 
 The primary end point was operative mortality. 
The secondary end point was composite morbidity. 
Composite morbidity was defined as occurrence of any 
one or more of the following: postoperative bleeding, 
reoperation, sepsis and intensive care unit (ICU) stay unit 
more than 48 hours.Patient’s  preoperative characteristics 
included in the analysis were age, gender, body weight, 
diagnosis, haemoglobin and haematocrite level, genetic 
syndrome, mechanical ventilator use and prostaglandine 
use. Intraoperative characteristics were aortic cross 
clamp (AoX) and cardiopulmonary bypass (CPB) use, 
sternotomi approach, graft diameter, competitive flow, 
pulmonary repair and atrial septectomy. Postoperative 
characteristics including haemoglobin, haematocrite 
and activated partial thromboplastine time (aPTT) 
level.  Age was divided into four categories, age under 
28 days, 29-365 days, 366-1825 days and age more 
than 1825 days. Haemoglobin level divided into 15% 
and more and under 15%. Haematocrite level will be 
categorized into 45% and more and less than 45%. 
Statistical Analysis
Statistical analysis was performed with SPSS software 
Statistics 20 (IBM, SPSS, Inc., Chicago, Illinois). 
Normality of data distribution was assessed by 
Kolmogorov-Smirnov test. Categorical variables are 
expressed as number and percentage, and comparisons 
are done using chi-square or Fisher exact test. 
Continuous variables are presented as mean + standard 
deviation or as median and interquartile range, 
Table 1. Outcome of modified Blalock-Taussig shunt
Variable <28 days(n=28)
29-365
(n=146)
366-1825
(n=138)
>1825
(n=88) p-value
Mortality 9 (32,1%) 29 (19,9%) 5 (3,6%) 7 (8%) <0,001
Morbidity 17 (63%) 59 (40,7%) 32 (23,2%) 23 (26,7 %) <0,001
Bleeding 11 (39,3%) 47 (32,4%) 25 (18,1%) 17 (19,3%) 0,006
Sepsis 5 (18,5%) 14 (9,8%) 2 (1,4%) 1 (1,1%) <0,001
Redo MBTS 4 (14,8%) 3 (2,1%) 9 (6,5%) 9 (10,2%) 0,019
ICU > 48 jam 23 (85,2%) 97 (67,4%) 50 (36,2%) 36 (51,9%) <0,001
a median (minimum-maksimum)
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Table 2. Univariate Analysis for predictors of mortality and morbidity
Variable
Mortality
p-value
Morbidity
p-value
Yes No Yes No
Age ≤28 days
29-365 days
366-1825 days
>1825 days
9 (18%)
29 (58%)
5 (10%)
7 (14%)
19 (5,4%)
117 (33,4%)
133 (38%)
81 (23,1%)
0,004b 26 (10,6%)
114 (46,5%)
63 (25,7%)
42 (17,1%)
1 (0,7%)
31 (20,3%)
75 (49%)
46 (30,1%)
<0,001a
Body weight <3kg
≥3 kg
11 (22%)
39 (10,5%)
14 (4,1%)
333 (89,5%)
<0,001b 20 (8,2%)
223 (91,8%)
5 (3,3%)
147 (96,7%)
0,05a
Ventilator Yes
No
15 (30%)
35 (10,2%)
41 (11,7%)
309 (89,8%)
<0,001a 50 (20,4%)
195 (79,6%)
5 (3,3%)
148 (96,7%)
<0,001a
Prostaglandin Yes
No
18 (36%)
32 (9,6%)
49 (14%)
301 (90,4%)
<0,001a 61 (24,9%)
184 (75,1%)
4 (2,6%)
149 (97,4%)
<0,001a
Hb (pre) Hb >15g/dl 
Hb ≤15g/dl
23 (46%)
27 (20,6%)
246 (70,3%)
104 (79,4%)
0,001a 142 (58%)
103 (42%)
127 (83%)
26 (17%)
<0,001a
Ht (pre) Ht >45% 
Ht ≤45%
21 (42%)
29 (25,9%)
267 (76,3%)
83 (74,1%)
<0,001a 156 (63,7%)
89 (36,3%)
132 (86,3%)
21 (13,7%)
<0,001a
Univentrikuler Yes
No
21 (17,1%)
29 (10,5%)
102 (82,9%)
248 (89,5%)
0,065a 83 (33,9%)
162 (66,1%)
39 (25,5%)
114 (74,5%)
0,077a
Diagnosis PA-IVS
PA-VSD
TOF
PA-CAVSD
Ebstein
12 (24%)
20 (40%)
7 (14%)
3 (6%)
1 (2%)
32 (9,1%)
128 (36,6%)
114 (32,6%)
10 (2,9%)
1 (0,3%)
0,002a
0,235b
36 (14,7%)
97 (39,6%)
55 (22,4%)
10 (4,1%)
2 (0,8%)
7 (4,6%)
50 (32,7%)
66 (43,1%)
3 (2,0%)
-
0,002a
0,526b
Competitive flow Yes
No
13 (26%)
37 (13,6%)
114 (32,6%)
236 (86,4%)
0,418a 82 (33,5%) 45 (29,4%) 0,398a
Sternotomi Yes
No
47 (94%)
3 (2,2%)
216 (61,7%)
134 (97,8%)
<0,001a 186 (71,3%)
59 (24,1%)
75 (28,7%)
78 (51%)
<0,001a
Transfusi Yes
No
17 (34,7%)
32 (10,9%)
88 (25,1%)
262 (89,1%)
0,155a 99 (40,4%)
146 (59,6%)
6 (3,9%)
147 (96,1%)
<0,001a
Hb (post) >14g/dl
≤14g/dl
22 (47,8%)
24 (16,1%)
225 (64,3%)
125 (83,9%)
0,03a 128 (52,5%)
116 (47,5%)
119 (78,3%)
33 (21,7%)
<0,001a
Ht (post) >45%
≤45%
17 (37%)
29 (63%)
214 (61,1%)
136 (38,9%)
0,002a 120 (49,2%)
124 (50,8%)
111 (73%)
41 (27%)
<0,001a
aPTT ≥60 s
<60 detik
19 (47,5%)
14 (35%)
55 (16,3%)
242 (71,8%)
<0,001a 59 (25,4%)
141 (60,8%)
15 (10,3%)
115 (79,3%) <0,001a
CPB Yes
No
24 (30,8%)
26 (8,1%)
54 (69,2%)
296 (91,9%)
<0,001b 55 (22,4%)
190 (77,6%)
22 (14,4%)
131 (85,6%)
0,047a
AoX Yes
No
14 (28%)
36 (10,3%)
35 (10%)
315 (89,7%)
<0,001a 36 (14,7%)
209 (85,3%)
12 (7,8%)
141 (92,2%)
0,041a
Anastomosis Innominata artery-PA 
Subclavia-PA
Aorta-PA
36 (72%)
8 (16%)
6 (12%)
195 (56%)
140 (40,2%)
10 (2,9%)
0,032a 163 (66,8%)
70 (28,7%)
9 (3,7%)
66 (43,4%)
78 (51,3%)
7 (4,6%)
<0,001a
Atrial septectomy Yes
No
12 (24%)
38 (10m6%)
30 (8,6%)
320 (89,4%)
0,001a 33 (13,5%)
212 (86,5%)
8 (5,2%)
145 (94,8%)
0,009a
PA repair Yes
No
3 (6%)
47 (12,1%)
9 (2,6%)
341 (87,8%)
0,18b 5 (2%)
240 (98%)
7 (4,6%)
146 (95,4%)
0,226b
ap value using chi square test. bp value using Fisher’s Exact test. 
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depending on the normality of their distribution. 
Comparison of continuous variables are consequently 
analyzed by unpaired t test or Mann-Whitney test. 
Analysis of predictors for operative mortality was based 
on a multivariable stepwise logistic regression model 
(backward likelihood ratio).  Risk factors were identified 
by the odds ratio (OR) and 95%confidence interval (CI) 
estimation. A p value <.05 was considered statistically 
significant.
Results
A total of 449 patients met the inclusion criteria. Of these, 
46 patients with concomitant surgery and 3 patients lost 
to follow up after discharged were excluded.  Finally, 
400 patients were included in this study. The median 
age at operation was 572 days (7-12710 days), with 
28 patients (7%) younger than 29 days, 146 patients 
(36,5%)  at age 29-365 days, 138 patients (34,5%) at 
age 366-1825 days and 88 patients (22%) at age more 
than 1825 days. In this study, overall, 50 patients did 
not survive after the MBTS (12,5% mortality) with the 
highest mortality rate at age younger than 29 days and 
29-365 days old. The composite morbidity, as defined, 
occurred in 131 patients (32,9%), including 100 
patients (25,1%) with abnormal bleeding, 22 patients 
(5,6%) with sepsis, 25 patients (6,3%) with redo MBTS 
and 206 patients (51,9%) with ICU stay more than 48 
hours (table 1).
 Bivariate statistical analysis was performed on 
factors affecting MBTS operative mortality and 
composite morbidity. The variable to be tested is a 
variable considered to have an effect on the operative 
mortality of MBTS based on previous research. Table 
2 shows bivariate analysis between the independent 
variables to operative mortality and composite 
morbidity. We observed that death was significantly 
increase with weight of less than 3 kg (OR 5,876, 
95%CI 1,872-18,441; p <0.05), whereas the hematocrit 
level of preoperative> 45 (OR 0,106; 95%CI 0,02-
0,579; p <0,05) and APTT <60 seconds (OR 0.241; 
95%CI 0.108-0.536; p <0.05) will reduce the risk of 
operative mortality. Neonatal age although it has a role 
in increasing mortality, but not statistically significant 
in multivariate analysis. (OR 0.869; 95%CI 0.232-
3.251; p> 0.05) (table 3). Factors that were significantly 
associated with composite morbidity included presence 
of history of transfusion (OR 17,048, 95%CI 6,608-
43,984, p <0,05), mechanical ventilation (OR 8,554; 
95%CI 2,476-29,548, p <0,05), use of prostaglandin 
(OR 6,273; 95%CI 2,084-18,881 , p <0.05). While 
APTT levels <60 seconds will decrease morbidity (OR 
0.434, 95%CI 0.248-0.759, p <0.05) Neonatal age 
although it has a role in increasing mortality, but not 
statistically significant in multivariate analysis. (OR 
4,671; 95%CI 0,533-40,920, p> 0,05)(table 4).
Discussion
Operative mortality after MBTS in this study was 
obtained in 50 patients (12.5%) with the largest 
proportion in the age group ≤ 28 days (32.1%). This rate 
is greater than the study by Singh et al that get a number 
4,5% for overall mortality and 8% for neonates.(5) 
Table 3. Multivariate analysis of operative mortality after MBTS
Variable OR 95%CI p-value
Age ≤ 28 days 0,869 0,232 – 3,251 0,835a
Body weight < 3 kg 5,876 1,872 – 18,441 0,002a
aPTT < 60 seconds 0,241 0,108 – 0,536 <0,001a
Haematocrite level >45% preoperatively 0,106 0,020 ± 0,579 0,009a
ap value is obtained through logistic regression for multivariate analysis
Table 4. Multivariate analysis of morbidity after MBTS
Variable OR 95%CI p-value
Age ≤28 days 4,671 0,533-40,920 0,161a
PRC transfusion >6ml/kg 17,048 6,608-43,984 <0,001a
Preoperative ventilator 8,554 2,476-29,548 0,001a
Prostaglandine E1 use 6,273 2,084-18,881 0,001a
aPTT < 60 seconds 0,434 0,248-0,759 0,003a
ap value is obtained through logistic regression for multivariate analysis
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Differences in the characteristics of the samples in both 
studies may explain the presence of higher mortality 
differences in our study. In the study of Singh et al, the 
method used was thoracotomy and the study did not 
include patients with PA-IVS in their research samples. 
In this study, sternotomy was performed in 57.4% of 
cases and PA-IVS morphology was present in 11% of 
the population. Both of these variables were shown to 
have a significant association to the increase in MBTS 
operative mortality in bivariate analysis.
 In this population, we found that age did not affect 
mortality rates after the MBTS. Weight less than 3 kg 
was known to increase mortality by 5.8 times in this 
study (OR 5.876, 95%CI 1,872-18,441; p = 0.002). 
Another study conducted by Petrucci et al, found that 
weight less than 3 kg as a predictor of operative mortality. 
The mechanism that plays a role is the unavailability of 
graft smaller than 3mm and smaller pulmonary artery 
size and consequent complications due to the more 
frequent use of prostaglandins in this population.(6) 
In this study, in patients with BB <3 kg, the MBTS 
procedure was performed with a sternotomy technique 
with a proportion of 100%. this approach often leads 
to excessive shunt flows since the graft is fitted more 
proximal and tends to use larger sizes thus increasing the 
risk of overcirculation.(7)
 Hematocrit levels were greater than 45% when 
preoperative decreased mortality by 9 times (OR 0.106; 
95%CI 0.020-0.579; p = 0.009). In this study, in 
bivariate analysis, hematocrit levels greater than 45% 
were associated with fewer bleeding events (OR 0.656; 
95%CI 0.466-0.924, p = 0.018). Decreased mortality 
in these circumstances was due to decreased risk of 
bleeding. Hypovolemia due to bleeding in cyanotic PJB 
may exacerbate the cyanotic condition due to increase 
right to left shunt.(8) Decreased blood flow may cause 
stasis in MBTS and result in thrombosis.
 APTT levels <60 seconds will decrease mortality 
by up to 4 times (OR 0.241; IK95% 0.108-0.536; p 
<0.001). Based on the literature, the aPTT target to 
be achieved is 60-90 seconds.(9) The risk of thrombosis 
will increase at low levels of aPTT. However, in a study 
conducted by Kucuk et al, obtained aPTT levels of 34.95 
seconds as a predictor of the incidence of thrombosis 
in MBTS. (10) This lower aPTT level that predicted 
thrombosis in MBTS suggests that there are different 
therapeutic targets in different populations. However, in 
this study, an aPTT analysis of less than 40 seconds was 
not done due to the limited number of samples.
From a multivariate analysis of postoperative morbidity, 
a PRC transfusion of more than 6 ml / kg, preoperative 
use of mechanical ventilation, preoperative use 
of prostaglandin E1 would increase postoperative 
morbidity. Meanwhile, an aPTT levels <60 seconds at 4 
h postoperatively decrease postoperative morbidity.  In 
this study, a transfusion of PRC greater than 6 ml / kg 
was a predictor of an increase in postoperative morbidity 
of MBTS (OR 17,048; IK95% 6,608-43,984, p <0.001 
In this study, a transfusion of PRC greater than 6 ml / kg 
was a predictor of an increase in postoperative morbidity 
(OR 17,048; IK95% 6,608-43,984, p <0.001). This 
is associated with the risk of transmission of infection 
through blood products. In the study by Dorneles et al, 
transfusion in patients after heart surgery was known 
to be associated with an increased risk of mortality by 
77% and an infection risk of 76%. This complication 
is associated with the incidence of transfusion reactions 
and transmission of infection.(11) 
 Preoperative use of mechanical ventilation increased 
morbidity by 8.5 times (OR 8,554; IK95% 2,476-
29,548; p <0.001). In bivariate analysis, the use of 
mechanical ventilation increases the length of ICU 
care over 48 hours by 1.8 times (OR 1.878, IK95% 
1,610-2,189, p <0.001). The mechanism involved is 
that the use of mechanical ventilation will increase the 
pulmonary circulatory resistance so that in this group 
of patients it will be more difficult to regulate the ratio 
of pulmonary and systemic blood circulation.(6) The 
Use of prostaglandin E1 would increase postoperative 
morbidity of MBTS by 6.2 times (OR 6.273; IK95% 
2.084-18,881; p = 0.001). This is due to an increase in 
pulmonary vascular resistance and increased long-term 
complications in long-term use or sudden termination 
of Prostaglandin E1. Increased pulmonary vascular 
resistance will increase the occlusion occurrence due to 
stasis in the MBTS graft.(7)
 Our study has a number of limitations, including a 
retrospective design and the voluntary nature of data- 
base, which limit the thorough capture of all relevant 
data. It is possible that some data might be underreported, 
such as PDA and MAPCAs ligation at the time of the 
MBTS procedure. The surgeries were performed by 
multiple surgeons, and therefore significant differences 
in operation techniques and hemostatic techniques may 
have have been present.
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 In summary, There is a difference in postoperative 
mortality and postoperative morbidity based on age 
criteria. Our study also demonstrates the continued 
significant risk of death in patients with low weight. 
Predictors of postoperative morbidity of MBTS include 
PRC transfusion over 6ml / kg, use of preoperative 
mechanical ventilation, and aPTT levels <60 seconds 
after 4 hours postoperatively.
Study Limitation 
We would like to acknowledge that difference in 
pathogenesis and course of conditions might  arise from 
variations of cardiac malformations that are included 
in this study. Also we did not have any data regarding 
history of prematurity or any pregnancy insult that 
might contribute to these malformations 
Conclusion
Operative mortality rate significantly different among 
age criteria but it was not proven as an operative 
mortality predictors.
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